Ratings by Barclays (Glen Santangelo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/14/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2026 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/18/2026 | Indivior | INDV | New Coverage | Overweight (N/A) |
38.01 (40.54) |
6.66% | Details | |
| 6/17/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/1/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2026 | Phreesia Inc. | PHR | Downgrade | Equalweight (Overweight) |
9.19 (10.71) |
16.54% | Details | |
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Equalweight (Overweight) |
23.39 (21.52) |
-7.99% | Details | |
| 5/6/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2026 | Claritev | CTEV | New Coverage | Overweight (N/A) |
21.91 (30.39) |
38.7% | Details | |
| 4/8/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/27/2026 | Phathom Pharmaceuticals | PHAT | Upgrade | Overweight (Equalweight) |
10.47 (10.94) |
4.49% | Details | |
| 3/26/2026 | Teladoc | TDOC | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/23/2026 | Alvotech SA | ALVO | Maintain | Underweight (N/A) |
|
Details | ||
| 3/23/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2026 | ANI Pharmaceuticals | ANIP | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2026 | Align Technology | ALGN | Upgrade | Overweight (Equalweight) |
164.23 (176.76) |
7.63% | Details | |
| 3/11/2026 | Hims and Hers | HIMS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/9/2026 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/6/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | Align Technology | ALGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/25/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | Bausch Health Companies | BHC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/24/2026 | Organon & Co. | OGN | Maintain | Underweight (N/A) |
|
Details | ||
| 2/24/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2026 | TalkSpace | TALK | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/18/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Overweight (N/A) |
41.25 (39.79) |
-3.54% | Details | |
| 1/9/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/16/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2025 | Organon & Co. | OGN | New Coverage | Underweight (N/A) |
7.14 (13.52) |
89.36% | Details | |
| 12/9/2025 | Collegium Pharmaceutical | COLL | New Coverage | Overweight (N/A) |
47.91 (36.08) |
-24.69% | Details | |
| 12/9/2025 | Amphastar Pharmaceuticals | AMPH | New Coverage | Equalweight (N/A) |
26.77 (19.75) |
-26.22% | Details | |
| 12/9/2025 | Phathom Pharmaceuticals | PHAT | New Coverage | Equalweight (N/A) |
14.58 (10.94) |
-24.97% | Details | |
| 12/9/2025 | Teva Pharma | TEVA | New Coverage | Overweight (N/A) |
28.46 (32.03) |
12.54% | Details | |
| 12/9/2025 | Amneal Pharmaceuticals | AMRX | New Coverage | Overweight (N/A) |
12.18 (17.85) |
46.55% | Details | |
| 12/9/2025 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
81.77 (59.85) |
-26.81% | Details | |
| 12/9/2025 | Alvotech SA | ALVO | New Coverage | Underweight (N/A) |
5.47 (3.46) |
-36.75% | Details | |
| 12/9/2025 | Viatris | VTRS | New Coverage | Overweight (N/A) |
10.93 (17.29) |
58.19% | Details | |
| 12/9/2025 | Pacira Pharmaceuticals | PCRX | New Coverage | Equalweight (N/A) |
23.99 (25.61) |
6.75% | Details | |
| 12/9/2025 | Bausch Health Companies | BHC | New Coverage | Equalweight (N/A) |
6.93 (4.83) |
-30.3% | Details | |
| 12/9/2025 | Elanco Animal Health | ELAN | New Coverage | Overweight (N/A) |
21.90 (25.83) |
17.95% | Details | |
| 12/9/2025 | Teladoc | TDOC | New Coverage | Equalweight (N/A) |
7.59 (9.43) |
24.24% | Details | |
| 12/9/2025 | Progyny | PGNY | New Coverage | Overweight (N/A) |
24.02 (31.93) |
32.93% | Details | |
| 12/9/2025 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
20.29 (10.71) |
-47.22% | Details | |
| 12/9/2025 | TalkSpace | TALk | New Coverage | Equalweight (N/A) |
3.08 (5.21) |
69.16% | Details | |
| 12/9/2025 | Zoetis Inc. | ZTS | New Coverage | Equalweight (N/A) |
118.65 (76.56) |
-35.47% | Details | |
| 12/9/2025 | Henry Schein | HSIC | New Coverage | Overweight (N/A) |
73.62 (87.82) |
19.29% | Details | |
| 12/9/2025 | Envista Holdings Corp. | NVST | New Coverage | Overweight (N/A) |
20.23 (26.74) |
32.18% | Details | |
| 12/9/2025 | Cencora Inc | COR | New Coverage | Overweight (N/A) |
339.66 (307.90) |
-9.35% | Details | |
| 12/9/2025 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
714.10 (567.44) |
-20.54% | Details | |
| 12/9/2025 | Cardinal Health | CAH | New Coverage | Overweight (N/A) |
198.83 (228.52) |
14.93% | Details | |
| 12/9/2025 | Lifestance Health Group | LFST | New Coverage | Overweight (N/A) |
6.48 (11.58) |
78.7% | Details | |
| 12/9/2025 | GoodRx Holdings Inc. | GDRX | New Coverage | Underweight (N/A) |
2.71 (3.14) |
15.87% | Details | |
| 12/9/2025 | McKesson | MCK | New Coverage | Overweight (N/A) |
808.62 (841.39) |
4.05% | Details | |
| 12/9/2025 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
94.51 (97.67) |
3.34% | Details | |
| 12/9/2025 | Doximity Inc | DOCS | New Coverage | Overweight (N/A) |
45.93 (21.52) |
-53.15% | Details | |
| 12/9/2025 | Align Technology | ALGN | New Coverage | Equalweight (N/A) |
157.21 (164.23) |
4.47% | Details |
